22.00
전일 마감가:
$21.31
열려 있는:
$21.1
하루 거래량:
8.30M
Relative Volume:
1.11
시가총액:
$5.85B
수익:
$13.30B
순이익/손실:
$-39.39M
주가수익비율:
-36.09
EPS:
-0.6096
순현금흐름:
$2.80B
1주 성능:
+18.47%
1개월 성능:
+52.25%
6개월 성능:
+48.15%
1년 성능:
+28.58%
오스카 헬스 Stock (OSCR) Company Profile
명칭
Oscar Health Inc
전화
(646) 403-3677
주소
75 VARICK STREET, NEW YORK
Compare OSCR vs UNH, CVS, ELV, CI, HUM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
OSCR
Oscar Health Inc
|
22.00 | 5.67B | 13.30B | -39.39M | 2.80B | -0.6096 |
|
UNH
Unitedhealth Group Inc
|
384.44 | 345.08B | 449.71B | 12.81B | 19.67B | 13.24 |
|
CVS
Cvs Health Corp
|
92.22 | 115.54B | 407.94B | 2.90B | 7.39B | 2.2771 |
|
ELV
Elevance Health Inc
|
381.75 | 82.10B | 200.42B | 5.24B | 6.45B | 23.50 |
|
CI
Cigna Group
|
289.07 | 76.20B | 278.13B | 6.74B | 7.66B | 23.60 |
|
HUM
Humana Inc
|
274.26 | 33.01B | 137.20B | 1.15B | 1.27B | 9.3439 |
오스카 헬스 Stock (OSCR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-20 | 업그레이드 | Jefferies | Underperform → Hold |
| 2026-02-12 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2026-01-09 | 업그레이드 | UBS | Sell → Neutral |
| 2026-01-05 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2025-12-11 | 개시 | Stephens | Equal-Weight |
| 2025-11-26 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-10-14 | 개시 | Goldman | Neutral |
| 2025-07-25 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2025-07-15 | 다운그레이드 | UBS | Neutral → Sell |
| 2025-07-14 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-11 | 다운그레이드 | Wells Fargo | Equal Weight → Underweight |
| 2025-07-02 | 개시 | Barclays | Underweight |
| 2025-06-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2025-03-13 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-10 | 개시 | Jefferies | Underperform |
| 2024-11-06 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2024-10-07 | 개시 | UBS | Neutral |
| 2024-06-26 | 개시 | Piper Sandler | Overweight |
| 2024-05-30 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2024-05-30 | 개시 | Robert W. Baird | Outperform |
| 2024-03-22 | 개시 | Raymond James | Outperform |
| 2023-11-02 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-06-06 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2022-11-16 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-11-14 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-06-15 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2022-05-26 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-02-14 | 다운그레이드 | Goldman | Neutral → Sell |
| 2022-01-06 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2021-12-14 | 개시 | Goldman | Sell |
| 2021-09-10 | 개시 | Cowen | Market Perform |
| 2021-03-30 | 개시 | Wells Fargo | Overweight |
| 2021-03-29 | 개시 | BofA Securities | Buy |
| 2021-03-29 | 개시 | Cowen | Market Perform |
| 2021-03-29 | 개시 | Credit Suisse | Outperform |
| 2021-03-29 | 개시 | Goldman | Buy |
| 2021-03-29 | 개시 | Morgan Stanley | Overweight |
모두보기
오스카 헬스 주식(OSCR)의 최신 뉴스
Oscar Health, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year - Yahoo Finance
Oscar Health (NYSE:OSCR) Upgraded at Zacks Research - MarketBeat
Why Is Oscar Health Stock Trending Right Now - Kalkine Media
Oscar Health (NYSE:OSCR) Raised to "Strong-Buy" at Wall Street Zen - MarketBeat
Oscar Health, Inc. Stock 12‑Month Price Target Raised to $20.09, Implies 4% Downside - TradingView
Why Oscar Health (OSCR) Is Up 13.1% After Record Q1 Profit Surge And Membership Growth - simplywall.st
Oscar Health | 10-Q: Q1 2026 Earnings Report - Moomoo
Vanguard Group Inc. Grows Holdings in Oscar Health, Inc. $OSCR - MarketBeat
OSCR Maintained by UBS -- Price Target Raised to $20.00 - GuruFocus
OSCR Maintained by Barclays -- Price Target Raised to $21 - GuruFocus
OSCR Maintains by Baird -- Price Target Raised to $19.00 - GuruFocus
Oscar Health Stock Soars 10.59% to Day High of $20.07 - Markets Mojo
Why Oscar Health, Inc. (OSCR) outpaced the stock market today - MSN
Oscar Health (OSCR) Is Up 10.7% After Record Q1 2026 Profitability And Reaffirmed GuidanceHas The Bull Case Changed? - Yahoo Finance
[10-Q] Oscar Health, Inc. Quarterly Earnings Report - Stock Titan
Why Oscar Health Stock Is Trending Right Now - Kalkine Media
UBS Adjusts Price Target on Oscar Health to $20 From $15, Maintains Neutral Rating - marketscreener.com
Robert W. Baird Issues Positive Forecast for Oscar Health (NYSE:OSCR) Stock Price - MarketBeat
Oscar Health, Inc. (NYSE:OSCR) Q1 2026 Earnings Call Transcript - Insider Monkey
Oscar Health Earnings Call Signals Profitable Scale - TipRanks
Oscar Health (NYSE:OSCR) Releases Earnings Results, Beats Estimates By $0.96 EPS - MarketBeat
Oscar Health, Inc. Q1 2026 Earnings Call Summary - Yahoo Finance
Oscar Health OSCR Q1 2026 Earnings Transcript - AOL.com
MSN Money - MSN
Oscar Health Stock Jumps After Q1 Profit More Than Doubles and 2026 Outlook Holds - TechStock²
Oscar Health (OSCR) Stock Soars 11% on Record-Breaking Quarterly Earnings - MEXC Exchange
Oscar Health, Inc. (OSCR) beats Q1 earnings estimates - MSN
Oscar Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Oscar Health (OSCR) Stock Jumps 11% After Crushing Earnings Estimates - MEXC Exchange
AMD Just Soared 20% on Earnings. Is It Still a Buy or Time to Take Profits? - The Motley Fool
Earnings call transcript: Oscar Health Q1 2026 surges past earnings forecasts - Investing.com
Oscar Health stock rises after Q1 earnings beat (OSCR:NYSE) - Seeking Alpha
Oscar Health Earnings Review: The Best Q1 Scenario We Could Hope For (NYSE:OSCR) - Seeking Alpha
Full Transcript: Oscar Health Q1 2026 Earnings Call - Benzinga
Oscar Health, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Oscar Health (OSCR) jumps after major earnings beat and margin improvement - Yahoo Finance
OSCR Stock On Track For 6-Month High: What’s Driving This Earnings Rally? - Stocktwits
Oscar Health, Inc. (OSCR) Beats Q1 Earnings Estimates - Yahoo Finance
Oscar Health beats Q1 estimates on lower medical costs, reaffirms full-year guidance - Sherwood News
Oscar Health Q1 Adjusted Earnings, Revenue Rise - marketscreener.com
Oscar Health stock surges 11% on strong earnings beat By Investing.com - Investing.com South Africa
(OSCR) Oscar Health Expects 2026 Revenue Range $18.7B$19B, vs. FactSet Est of $18.78B - marketscreener.com
Oscar Health (NYSE:OSCR) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 12% - Barchart.com
Earnings Flash (OSCR) Oscar Health, Inc. Reports Q1 Revenue $4.65B - marketscreener.com
Earnings Flash (OSCR) Oscar Health Posts Q1 EPS $2.07 - marketscreener.com
Oscar Health stock surges 11% on strong earnings beat - Investing.com UK
Oscar Health (NYSE: OSCR) Q1 2026 profit jumps as revenue grows - Stock Titan
Oscar Health Announces Strong Financial Results for First Quarter 2026 And Reaffirms 2026 Guidance - The Joplin Globe
BRIEF-Oscar Health Q1 Revenue USD 4,647.194 Million Vs. IBES Estimate USD 4,916 Million - TradingView
Oscar Health Reports Record Profit As Obamacare Enrollment Jumps - Yahoo Finance
Wolfe Research initiates coverage of Oscar Health (OSCR) with peer perform recommendation - MSN
오스카 헬스 (OSCR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):